挺好的
任务形式越来越多，好用
App is temporarily unavailable
云药客
Published by: 超慧 裴
Description
云药客——聪明的医药人都在这里
这是一款精准的移动医药营销平台，用户均为医药圈内人士，在这里，你可以直接管理查看你的工作过程数据和营销数据，以及进行推广交互
【工作】：让你精准掌控推广过程中的过程数据以及可以追踪的结果数据，让你对于工作中的数据轻松知道
【我的】：提供方便快捷的个人数据管理
这里是云药客，这里是属于医药人的家园，这里还有很多精彩等你挖掘。
这是一款精准的移动医药营销平台，用户均为医药圈内人士，在这里，你可以直接管理查看你的工作过程数据和营销数据，以及进行推广交互
【工作】：让你精准掌控推广过程中的过程数据以及可以追踪的结果数据，让你对于工作中的数据轻松知道
【我的】：提供方便快捷的个人数据管理
这里是云药客，这里是属于医药人的家园，这里还有很多精彩等你挖掘。
Screenshots
云药客 FAQ
-
Is 云药客 free?
Yes, 云药客 is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is 云药客 legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does 云药客 cost?
云药客 is free.
-
What is 云药客 revenue?
To get estimated revenue of 云药客 app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Norway yet.
Ratings History
云药客 Reviews
云药客 Installs
Last 30 days
云药客 Revenue
Last 30 days云药客 Revenue and Downloads
Gain valuable insights into 云药客 performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
- 超慧 裴
- Languages
- English, Chinese
- Recent release
- 1.2.60 (1 year ago )
- Released on
- Dec 7, 2019 (5 years ago )
- Also available in
- China, Poland, Italy, Japan, South Korea, Kuwait, Kazakhstan, Lebanon, Mexico, Malaysia, Nigeria, Netherlands, Norway, New Zealand, Peru, Philippines, Pakistan, India, Portugal, Romania, Russia, Saudi Arabia, Sweden, Singapore, Thailand, Türkiye, Taiwan, Ukraine, United States, Vietnam, South Africa, Dominican Republic, Argentina, Austria, Australia, Azerbaijan, Belgium, Brazil, Belarus, Canada, Switzerland, Chile, Colombia, Czechia, Germany, Denmark, United Arab Emirates, Algeria, Ecuador, Egypt, Spain, Finland, France, United Kingdom, Greece, Hong Kong SAR China, Hungary, Indonesia, Ireland, Israel
- Last Updated
- 3 months ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.